Human Genome Epidemiology Literature Finder
Records 1 - 10 (of 10 Records) |
Query Trace: Colorectal Neoplasms and MAX[original query] |
---|
Prostaglandin H synthase 2 variant (Val511Ala) in African Americans may reduce the risk for colorectal neoplasia. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2002 Nov 11 (11): 1305-15. Lin Henry J, Lakkides Karen M, Keku Temitope O, Reddy Srinivasa T, Louie Andrew D, Kau Irving H, Zhou Haiyan, Gim Jason S Y, Ma Hoang L, Matthies Carl F, Dai Aihua, Huang Hsiao-Fen, Materi Alicia M, Lin Jesse H, Frankl Harold D, Lee Eric R, Hardy Steven I, Herschman Harvey R, Henderson Brian E, Kolonel Laurence N, Le Marchand Loïc, Garavito R Michael, Sandler Robert S, Haile Robert W, Smith William |
Impact of KRAS and BRAF Gene Mutation Status on Outcomes From the Phase III AGITG MAX Trial of Capecitabine Alone or in Combination With Bevacizumab and Mitomycin in Advanced Colorectal Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 Jul 29 (19): 2675-82. Price Timothy J, Hardingham Jennifer E, Lee Chee K, Weickhardt Andrew, Townsend Amanda R, Wrin Joseph W, Chua Ann, Shivasami Aravind, Cummins Michelle M, Murone Carmel, Tebbutt Niall |
Mutation and association analyses of the candidate genes ESR1, ESR2, MAX, PCNA, and KAT2A in patients with unexplained MSH2-deficient tumors. Familial cancer 2012 Mar 11 (1): 19-26. Rahner Nils, Brockschmidt Felix F, Steinke Verena, Kahl Philip, Becker Tim, Vasen Hans F A, Wijnen Juul T, Tops Carli J M, Holinski-Feder Elke, Ligtenberg Marjolijn J L, Spruijt Liesbeth, Görgens Heike, Stemmler Susanne, Kloor Matthias, Dietmaier Wolfgang, , Schumacher Johannes, Nöthen Markus M, Propping Pet |
Relationship between 18F-fluorodeoxyglucose accumulation and KRAS/BRAF mutations in colorectal cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2012 Mar 18 (6): 1696-703. Kawada Kenji, Nakamoto Yuji, Kawada Mayumi, Hida Koya, Matsumoto Takuya, Murakami Teppei, Hasegawa Suguru, Togashi Kaori, Sakai Yoshiha |
Prognostic impact and the relevance of PTEN copy number alterations in patients with advanced colorectal cancer (CRC) receiving bevacizumab. Cancer medicine 2013 Jun 2 (3): 277-85. Price Timothy J, Hardingham Jennifer E, Lee Chee K, Townsend Amanda R, Wrin Joseph W, Wilson Kate, Weickhardt Andrew, Simes Robert J, Murone Carmel, Tebbutt Niall |
Genetic Alterations in Colorectal Cancer Have Different Patterns on 18F-FDG PET/CT. Clinical nuclear medicine 2015 Aug 40 (8): 621-6. Chen Shang-Wen, Lin Chien-Yu, Ho Cheng-Man, Chang Ya-Sian, Yang Shu-Fen, Kao Chia-Hung, Chang Jan-Gow |
Correlation of extended RAS and PIK3CA gene mutation status with outcomes from the phase III AGITG MAX STUDY involving capecitabine alone or in combination with bevacizumab plus or minus mitomycin C in advanced colorectal cancer. British journal of cancer 2015 Mar . Price T J, Bruhn M A, Lee C K, Hardingham J E, Townsend A R, Mann K P, Simes J, Weickhardt A, Wrin J W, Wilson K, Gebski V, Van Hazel G, Robinson B, Cunningham D, Tebbutt N |
Common genetic variation in ETV6 is associated with colorectal cancer susceptibility.
Nature communications 2016 May 7 11478. Wang Meilin, Gu Dongying, Du Mulong, Xu Zhi, Zhang Suzhan, Zhu Lingjun, Lu Jiachun, Zhang Rui, Xing Jinliang, Miao Xiaoping, Chu Haiyan, Hu Zhibin, Yang Lei, Tang Cuiju, Pan Lei, Du Haina, Zhao Jian, Du Jiangbo, Tong Na, Sun Jielin, Shen Hongbing, Xu Jianfeng, Zhang Zhengdong, Chen Jinf |
Effects of Metastatic Sites on Circulating Tumor DNA in Patients With Metastatic Colorectal Cancer. JCO precision oncology 2022 5 6 e2100535. Bando Hideaki, Nakamura Yoshiaki, Taniguchi Hiroya, Shiozawa Manabu, Yasui Hisateru, Esaki Taito, Kagawa Yoshinori, Denda Tadamichi, Satoh Taroh, Yamazaki Kentaro, Sunakawa Yu, Kato Takeshi, Goto Masahiro, Yuki Satoshi, Nishina Tomohiro, Oki Eiji, Shinozaki Eiji, Matsuhashi Nobuhisa, Takahashi Naoki, Tsuji Akihito, Ohtsubo Koushiro, Wakabayashi Masashi, Ikeno Takashi, Hata Masayuki, Odegaard Justin I, Yoshino Takayu |
VEGF-A, VEGFR1 and VEGFR2 single nucleotide polymorphisms and outcomes from the AGITG MAX trial of capecitabine, bevacizumab and mitomycin C in metastatic colorectal cancer. Scientific reports 2022 01 12 (1): 1238. Chionh Fiona, Gebski Val, Al-Obaidi Sheren J, Mooi Jennifer K, Bruhn Maressa A, Lee Chee K, Chüeh Anderly C, Williams David S, Weickhardt Andrew J, Wilson Kate, Scott Andrew M, Simes John, Hardingham Jennifer E, Price Timothy J, Mariadason John M, Tebbutt Niall |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 06, 2024
- Content source: